Post-market Review of Ezetimibe – Targeted Stakeholder Forum
Page last updated: 28 October 2016
The Reference Group of the Post-market Review of ezetimibe has requested that a targeted Stakeholder Forum be held in Canberra on Friday 11 November 2016 to seek additional stakeholder input to further inform the Review. The forum will be specifically targeted to pharmaceutical sponsors who either have a current Pharmaceutical Benefit Scheme medicine listing for ezetimibe or in combination with ezetimibe, or propose to have one in the near future.
Stakeholders who wish to attend and have not received an invitation should submit an expression of interest to the Ezetimibe Review Secretariat by COB Friday 04 November 2016.
For more information see the Ezetimibe Review main page.